Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009880 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
A Phase 2 study of Gastric Cancer and Esophageal Cancer, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
NCT00009880 is a Phase 2 study of Gastric Cancer and Esophageal Cancer that has completed, run by Radiation Therapy Oncology Group. The trial reports 20 study locations across 13 states.
The verdict
NCT00009880, a Phase 2 study of Gastric Cancer and Esophageal Cancer, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy and radiation therapy may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of combination chemotherapy plus radiation therapy with and without fluorouracil in treating patients who have cancer of the esophagus or stomach.
Conditions Studied
Interventions
- DRUG cisplatin
- DRUG paclitaxel
- DRUG fluorouracil
- RADIATION radiation therapy
- BIOLOGICAL filgrastim
Study Locations (20)
Indiana
- Indiana University Cancer Center - Indianapolis
- Veterans Affairs Medical Center - Indianapolis (Roudebush) - Indianapolis
- Cancer Center at Ball Memorial Hospital - Muncie
- Memorial Hospital of South Bend - South Bend
- Union Hospital - Terre Haute
Florida
- University of Florida Shands Cancer Center - Gainesville
- Baptist-South Miami Regional Cancer Program - Miami
- CCOP - Mount Sinai Medical Center - Miami Beach
California
- City of Hope Comprehensive Cancer Center - Duarte
- Leavey Cancer Center at Northridge Hospital Medical Center - Northridge
Alabama
- Mobile Infirmary Medical Center - Mobile
Arizona
- Foundation for Cancer Research and Education - Phoenix
Hawaii
- Cancer Research Center of Hawaii - Honolulu
Illinois
- Methodist Medical Center of Illinois - Peoria
Iowa
- Wendt Regional Cancer Center at Finley Hospital - Dubuque
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00009880
The ClinicalTrials.gov registry entry for NCT00009880 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastric Cancer appearing as the primary indexed condition, and to 5 interventions - of which cisplatin is the first listed.
NCT00009880 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Indiana, Florida, California.
Frequently Asked Questions
What is clinical trial NCT00009880 about?
NCT00009880 is a clinical study titled "Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy and radiation therapy may kill more tumor cells. PURPOSE: Randomized phase II trial to comp...
What is the current status of trial NCT00009880?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-04.
What conditions does trial NCT00009880 study?
This clinical trial studies the following conditions: Gastric Cancer, Esophageal Cancer.
What interventions are being tested in trial NCT00009880?
The interventions under investigation include: cisplatin (DRUG), paclitaxel (DRUG), fluorouracil (DRUG), radiation therapy (RADIATION), filgrastim (BIOLOGICAL).
Who is sponsoring clinical trial NCT00009880?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00009880 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RECRUITING · Phase 2
-
Combination of TATE and PD-1 Inhibitor in Liver Cancer
RECRUITING · Phase 2
-
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
RECRUITING · Phase 2
-
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
RECRUITING · Phase 2
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
-
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.